Abstract
Screening of 205 patients suffering from various diseases and healthy donors for the presence of serum antibodies to terminal repeat protein (TP) of Epstein-Barr virus was carried out using the indirect immunofluorescence technique. TP antibodies were detected exclusively in patients with undifferentiated nasopharyngeal carcinoma (in 30–40% of patients within this group). Evaluation of TP antibody titers before and after treatment revealed a correlation between the dynamics of these antibodies and the clinical prognosis of patients.
Similar content being viewed by others
References
M. A. Epstein,The Epstein-Barr Virus, Ed. B., G. Achong, Berlin (1979).
B. Frech, U. Zimber-Strobl, K.-O. Suentzenich,et al., J. Virol.,64, 2759–2767 (1990).
B. Frech, U. Zimber-Strobl, T. Yip,et al., J. Gen. Virol.,74, 811–818 (1993).
V. Gurtsevich, R. Ruiz, V. Stepina,et al., Int. J. Cancer,37, 375–381 (1986).
G. Laux, M. Perricaudet, and P. Farrell,EMBO J.,7, 769–774 (1988).
G. Laux, A. Economou, and P. J. Farrell,J. Gen. Virol.,70, 3079–3084 (1989).
D. Leibovitz and E. Kieff, in:The Human Herpes Viruses, Eds. B. Roizmanet al., New York, (1993), pp. 107–172.
G. Miller, in:Virology, Eds. B. Fieldset al., New York (1990), pp. 1821–1958.
M. Rowe, J. Fince, R. Szigeti, and G. Klein,J. Gen. Virol.,69, 1217–1228 (1988).
J. Sample, D. Leibowitz, and E. KieffJ. Virol.,63, 993–997 (1989).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 119, No. 3, pp. 311–314, March, 1995
Rights and permissions
About this article
Cite this article
Afanas'eva, T.A., Belousova, N.V., Kondrat'eva, T.T. et al. Immune response to the terminal repeat protein of epstein-barr virus in patients with undifferentiated nasopharyngeal carcinoma. Bull Exp Biol Med 119, 303–306 (1995). https://doi.org/10.1007/BF02445843
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02445843